Insider · CIK 0001181155

FRANK FRED

Reports to the SEC for 4 companies · INCLINE VILLAGE, NV

sec.gov

Transactions

Companies

Filings

CIK

0001181155

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-10-14	LFCRLIFECORE BIOMEDICAL, INC. \DE\A Award	Director	AAward	+8,303 sh	$10.42	+$86.5K	74,327
2020-10-14	LFCRLIFECORE BIOMEDICAL, INC. \DE\A Award	Director	AAward	+2,200 sh	$10.42	+$22.9K	76,527
2020-10-14	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−2,200 sh	—	—	0
2020-10-14	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−8,303 sh	—	—	0
2020-06-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)A Award	Director	AAward	+8,303 sh	—	—	8,303
2020-05-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\A Award	Director	AAward	+6,000 sh	$10.99	+$65.9K	66,024
2020-05-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	0
2019-10-15	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)A Award	Director	AAward	+2,200 sh	—	—	2,200
2019-05-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+4,240 sh	$9.91	+$42K	60,024
2019-05-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−4,240 sh	—	—	0
2019-05-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Units (RSU)A Award	Director	AAward	+6,000 sh	—	—	6,000
2019-04-29	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$6.66	+$33.3K	59,001
2019-04-29	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director	FTax Payment	−3,217 sh	$10.35	−$33.3K	55,784
2019-04-29	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Nonstatutory Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2018-05-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+4,240 sh	—	—	4,240
2018-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+4,286 sh	$13.65	+$58.5K	54,001
2018-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−4,286 sh	—	—	0
2018-03-06	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.77	+$28.8K	51,892
2018-03-06	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director	FTax Payment	−2,177 sh	$13.25	−$28.8K	49,715
2018-03-06	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Nonstatutory Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	5,000
2017-06-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+4,286 sh	—	—	4,286
2017-05-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,282 sh	$13.50	+$71.3K	46,892
2017-05-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−5,282 sh	—	—	0
2017-04-11	LFCRLIFECORE BIOMEDICAL, INC. \DE\S Sale	Director	SSale	−3,025 sh	$14.00	−$42.4K	41,610
2017-04-07	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.63	+$28.2K	46,610
2017-04-07	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director	FTax Payment	−1,975 sh	$14.25	−$28.1K	44,635
2017-04-07	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Nonstatutory Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	10,000
2016-05-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+3,475 sh	$11.46	+$39.8K	41,610
2016-05-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−3,475 sh	—	—	0
2016-05-26	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+5,222 sh	—	—	5,222
2016-05-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+5,282 sh	—	—	5,282
2016-05-03	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$11.00	+$55K	40,962
2016-05-03	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director	FTax Payment	−2,827 sh	$11.00	−$31.1K	38,135
2016-05-03	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · NonQualified Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−5,000 sh	$6.22	−$31.1K	0
2016-02-04	LFCRLIFECORE BIOMEDICAL, INC. \DE\S Sale	Director	SSale	−4,573 sh	$12.00	−$54.9K	35,962
2016-02-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\S Sale	Director	SSale	−5,627 sh	$12.00	−$67.5K	40,535
2015-05-29	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+4,219 sh	$14.29	+$60.3K	46,162
2015-05-29	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,219 sh	—	—	0
2015-05-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+3,475 sh	—	—	3,475
2015-04-08	LFCRLIFECORE BIOMEDICAL, INC. \DE\S Sale	Director	SSale	−6,549 sh	$14.56	−$95.4K	41,943
2015-04-07	LFCRLIFECORE BIOMEDICAL, INC. \DE\S Sale	Director	SSale	−13.5K sh	$14.78	−$199K	48,492
2015-02-18	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$6.85	+$68.5K	64,596
2015-02-18	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$8.19	+$41K	69,596
2015-02-18	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	−7,653 sh	$14.30	−$109K	61,943
2015-02-18	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · NonQualified Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−5,000 sh	$8.19	−$41K	0
2015-02-18	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · NonQualified Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−10K sh	$6.85	−$68.5K	0
2014-10-15	LFCRLIFECORE BIOMEDICAL, INC. \DE\S Sale	Director	SSale	−19.4K sh	$11.58	−$225K	54,596
2014-10-14	LFCRLIFECORE BIOMEDICAL, INC. \DE\S Sale	Director	SSale	−30.6K sh	$11.58	−$354K	73,996
2014-08-15	LFCRLIFECORE BIOMEDICAL, INC. \DE\S Sale	Director	SSale	−29.8K sh	$12.08	−$359K	104,596
2014-08-14	LFCRLIFECORE BIOMEDICAL, INC. \DE\S Sale	Director	SSale	−28.7K sh	$12.11	−$348K	134,349

Recent filings

Accepted (ET)
Oct 154
FRANK FRED0001593968-20-002036
SEC(opens sec.gov)
Jun 24
FRANK FRED0001628280-20-008850
SEC(opens sec.gov)
May 294
FRANK FRED0001628280-20-008624
SEC(opens sec.gov)
Oct 174
FRANK FRED0001628280-19-012372
SEC(opens sec.gov)
May 304
FRANK FRED0001628280-19-007411
SEC(opens sec.gov)
Apr 304
FRANK FRED0001628280-19-005156
SEC(opens sec.gov)
Jun 14
FRANK FRED0001437749-18-011101
SEC(opens sec.gov)
May 254
FRANK FRED0001437749-18-010774
SEC(opens sec.gov)
Mar 84
FRANK FRED0001437749-18-004232
SEC(opens sec.gov)

Companies

Address

C/O PDL BIOPHARMA, INC. 932 SOUTHWOOD BLVD

INCLINE VILLAGE, NV, 89451